Analyze Diet
Virology1987; 161(2); 321-331; doi: 10.1016/0042-6822(87)90124-3

Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV.

Abstract: The extent and nature of genomic variation among nine antigenically distinct EIAV isolates recovered during sequential clinical episodes from two experimentally infected ponies were examined by restriction fragment analysis and nucleotide sequencing. Only minor variations in restriction enzyme patterns were observed among the viral genomes. In contrast, env gene sequences of four isolates from one pony revealed numerous clustered base substitutions. Divergence in env gene nucleotide and deduced amino acid sequences between pairs of virus isolates ranged from 0.62 to 3.4% env gene mutation rates for isolates recovered during sequential febrile episodes were calculated to be greater than 10(-2) base substitutions per site per year. The degree and nature of env gene variation in EIAV is remarkably similar to the human immunodeficiency virus, suggesting common mechanisms for env gene variation among lentiviruses.
Publication Date: 1987-12-01 PubMed ID: 2825406DOI: 10.1016/0042-6822(87)90124-3Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates the genetic variation of a lentivirus called Equine Infectious Anemia Virus (EIAV) during infection. The results suggest that this variation, specifically in the envelope gene (env), is similar in nature and scale to the variation seen in HIV, implying a common mechanism for envelope gene change.

Research Methodology and Findings

  • The researchers studied the genomic variation in nine different EIAV isolates. These isolates were recovered from two ponies that were experimentally infected, with each pony experiencing different clinical episodes.
  • The extent and nature of genome variance were examined using restriction fragment analysis and nucleotide sequencing. The former technique is used for examining the length of DNA fragments, and the latter to determine the sequence of nucleotides in the DNA.
  • The study discovered only minor changes in the restriction enzyme patterns among the nine isolates, suggesting little genomic variance.
  • However, by contrast, the env gene sequences of four isolates from a single pony displayed many closely grouped base substitutions. Base substitution is a type of mutation involving replacement of the DNA base with another.
  • The divergence in the env gene nucleotide sequences and the associated, inferred amino acid sequences between pairs of virus isolates varied from 0.62 to 3.4%.
  • The researchers calculated the env gene mutation rates for the isolates recovered during sequential feverish occurrences. The results indicated the rate of greater than 10(-2) base substitutions per site per year.

Comparison with HIV and Conclusions

  • The results revealed that the degree and nature of the env gene variation in the EIAV were strikingly similar to those observed in HIV.
  • This likeness hints at a common mechanism for envelope gene variation among lentiviruses, a group of viruses including HIV and EIAV.
  • These findings contribute to our understanding of how lentiviruses evolve and persist during infection, a research area pivotal for disease treatment and eventual eradication efforts.

Cite This Article

APA
Payne SL, Fang FD, Liu CP, Dhruva BR, Rwambo P, Issel CJ, Montelaro RC. (1987). Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV. Virology, 161(2), 321-331. https://doi.org/10.1016/0042-6822(87)90124-3

Publication

ISSN: 0042-6822
NlmUniqueID: 0110674
Country: United States
Language: English
Volume: 161
Issue: 2
Pages: 321-331

Researcher Affiliations

Payne, S L
  • Department of Biochemistry, Louisiana State University, Baton Rouge 70803.
Fang, F D
    Liu, C P
      Dhruva, B R
        Rwambo, P
          Issel, C J
            Montelaro, R C

              MeSH Terms

              • Amino Acid Sequence
              • Animals
              • Antigenic Variation
              • Antigens, Viral / genetics
              • Base Sequence
              • DNA Restriction Enzymes
              • Genes, Viral
              • Genetic Variation
              • HIV / genetics
              • Horse Diseases / microbiology
              • Horses / microbiology
              • Infectious Anemia Virus, Equine / immunology
              • Molecular Sequence Data
              • Time Factors
              • Viral Envelope Proteins / genetics

              Grant Funding

              • CA-38851 / NCI NIH HHS

              Citations

              This article has been cited 47 times.
              1. Lee J, Malmberg JL, Wood BA, Hladky S, Troyer R, Roelke M, Cunningham M, McBride R, Vickers W, Boyce W, Boydston E, Serieys L, Riley S, Crooks K, VandeWoude S. Feline Immunodeficiency Virus Cross-Species Transmission: Implications for Emergence of New Lentiviral Infections.. J Virol 2017 Mar 1;91(5).
                doi: 10.1128/JVI.02134-16pubmed: 28003486google scholar: lookup
              2. Qian L, Han X, Liu X. Structural insight into equine lentivirus receptor 1.. Protein Sci 2015 May;24(5):633-42.
                doi: 10.1002/pro.2634pubmed: 25559821google scholar: lookup
              3. Liu C, Cook SJ, Craigo JK, Cook FR, Issel CJ, Montelaro RC, Horohov DW. Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.. Vet Immunol Immunopathol 2014 Oct 15;161(3-4):161-9.
                doi: 10.1016/j.vetimm.2014.08.001pubmed: 25176006google scholar: lookup
              4. Lee JS, Bevins SN, Serieys LE, Vickers W, Logan KA, Aldredge M, Boydston EE, Lyren LM, McBride R, Roelke-Parker M, Pecon-Slattery J, Troyer JL, Riley SP, Boyce WM, Crooks KR, VandeWoude S. Evolution of puma lentivirus in bobcats (Lynx rufus) and mountain lions (Puma concolor) in North America.. J Virol 2014 Jul;88(14):7727-37.
                doi: 10.1128/JVI.00473-14pubmed: 24741092google scholar: lookup
              5. Craigo JK, Montelaro RC. Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.. Viruses 2013 Dec 2;5(12):2963-76.
                doi: 10.3390/v5122963pubmed: 24316675google scholar: lookup
              6. Craigo JK, Ezzelarab C, Cook SJ, Chong L, Horohov D, Issel CJ, Montelaro RC. Envelope determinants of equine lentiviral vaccine protection.. PLoS One 2013;8(6):e66093.
                doi: 10.1371/journal.pone.0066093pubmed: 23785473google scholar: lookup
              7. Farley DC, Bannister R, Leroux-Carlucci MA, Evans NE, Miskin JE, Mitrophanous KA. Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors.. Hum Gene Ther Methods 2012 Oct;23(5):309-23.
                doi: 10.1089/hgtb.2012.102pubmed: 23121195google scholar: lookup
              8. Patel JR, Heldens JG, Bakonyi T, Rusvai M. Important mammalian veterinary viral immunodiseases and their control.. Vaccine 2012 Feb 27;30(10):1767-81.
                doi: 10.1016/j.vaccine.2012.01.014pubmed: 22261411google scholar: lookup
              9. Liu L, Wan Y, Wu L, Sun J, Li H, Li H, Ma L, Shao Y. Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine.. Retrovirology 2010 Sep 1;7:71.
                doi: 10.1186/1742-4690-7-71pubmed: 20807451google scholar: lookup
              10. Craigo JK, Barnes S, Zhang B, Cook SJ, Howe L, Issel CJ, Montelaro RC. An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.. Retrovirology 2009 Oct 20;6:95.
                doi: 10.1186/1742-4690-6-95pubmed: 19843328google scholar: lookup
              11. Tagmyer TL, Craigo JK, Cook SJ, Even DL, Issel CJ, Montelaro RC. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.. J Virol 2008 Apr;82(8):4052-63.
                doi: 10.1128/JVI.02028-07pubmed: 18234792google scholar: lookup
              12. Payne SL, Pei XF, Jia B, Fagerness A, Fuller FJ. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.. J Virol 2004 Mar;78(5):2478-85.
              13. Mealey RH, Zhang B, Leib SR, Littke MH, McGuire TC. Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.. Virology 2003 Sep 1;313(2):537-52.
                doi: 10.1016/s0042-6822(03)00344-1pubmed: 12954220google scholar: lookup
              14. Howe L, Leroux C, Issel CJ, Montelaro RC. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.. J Virol 2002 Nov;76(21):10588-97.
              15. Leroux C, Craigo JK, Issel CJ, Montelaro RC. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.. J Virol 2001 May;75(10):4570-83.
              16. Lonning SM, Zhang W, Leib SR, McGuire TC. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.. J Virol 1999 Apr;73(4):2762-9.
              17. Belshan M, Harris ME, Shoemaker AE, Hope TJ, Carpenter S. Biological characterization of Rev variation in equine infectious anemia virus.. J Virol 1998 May;72(5):4421-6.
              18. Payne SL, Qi XM, Shao H, Dwyer A, Fuller FJ. Disease induction by virus derived from molecular clones of equine infectious anemia virus.. J Virol 1998 Jan;72(1):483-7.
                doi: 10.1128/JVI.72.1.483-487.1998pubmed: 9420249google scholar: lookup
              19. Leroux C, Issel CJ, Montelaro RC. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.. J Virol 1997 Dec;71(12):9627-39.
              20. Zheng YH, Sentsui H, Nakaya T, Kono Y, Ikuta K. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain.. J Virol 1997 Jul;71(7):5031-9.
              21. Lichtenstein DL, Issel CJ, Montelaro RC. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.. J Virol 1996 Jun;70(6):3346-54.
              22. Burns DP, Collignon C, Desrosiers RC. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.. J Virol 1993 Jul;67(7):4104-13.
              23. Carvalho M, Kirkland M, Derse D. Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity.. J Virol 1993 Nov;67(11):6586-95.
              24. Greene WK, Meers J, del Fierro G, Carnegie PR, Robinson WF. Extensive sequence variation of feline immunodeficiency virus env genes in isolates from naturally infected cats.. Arch Virol 1993;133(1-2):51-62.
                doi: 10.1007/BF01309743pubmed: 8240017google scholar: lookup
              25. Martarano L, Stephens R, Rice N, Derse D. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.. J Virol 1994 May;68(5):3102-11.
              26. Kim CH, Casey JW. In vivo replicative status and envelope heterogeneity of equine infectious anemia virus in an inapparent carrier.. J Virol 1994 Apr;68(4):2777-80.
              27. Köppe B, Menéndez-Arias L, Oroszlan S. Expression and purification of the mouse mammary tumor virus gag-pro transframe protein p30 and characterization of its dUTPase activity.. J Virol 1994 Apr;68(4):2313-9.
              28. McGuire TC, Tumas DB, Byrne KM, Hines MT, Leib SR, Brassfield AL, O'Rourke KI, Perryman LE. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.. J Virol 1994 Mar;68(3):1459-67.
              29. Carey N, Dalziel RG. Sequence variation in the gp135 gene of Maedi visna virus strain EV1.. Virus Genes 1994 Mar;8(2):115-23.
                doi: 10.1007/BF01703610pubmed: 8073632google scholar: lookup
              30. Sellon DC, Fuller FJ, McGuire TC. The immunopathogenesis of equine infectious anemia virus.. Virus Res 1994 May;32(2):111-38.
                doi: 10.1016/0168-1702(94)90038-8pubmed: 8067050google scholar: lookup
              31. Cook RF, Berger SL, Rushlow KE, McManus JM, Cook SJ, Harrold S, Raabe ML, Montelaro RC, Issel CJ. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.. J Virol 1995 Mar;69(3):1493-9.
              32. Lichtenstein DL, Rushlow KE, Cook RF, Raabe ML, Swardson CJ, Kociba GJ, Issel CJ, Montelaro RC. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.. J Virol 1995 May;69(5):2881-8.
              33. Gerencer M, Valpotić I, Jukić B, Tomasković M, Basić I. Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS.. Arch Virol 1989;104(3-4):249-57.
                doi: 10.1007/BF01315547pubmed: 2523215google scholar: lookup
              34. Rwambo PM, Issel CJ, Adams WV Jr, Hussain KA, Miller M, Montelaro RC. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.. Arch Virol 1990;111(3-4):199-212.
                doi: 10.1007/BF01311054pubmed: 2162160google scholar: lookup
              35. Rasty S, Dhruva BR, Schiltz RL, Shih DS, Issel CJ, Montelaro RC. Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections.. J Virol 1990 Jan;64(1):86-95.
                doi: 10.1128/JVI.64.1.86-95.1990pubmed: 2152836google scholar: lookup
              36. O'Rourke KI, Besola ML, McGuire TC. Proviral sequences detected by polymerase chain reaction in peripheral blood cells of horses with equine infectious anemia lentivirus.. Arch Virol 1991;117(1-2):109-19.
                doi: 10.1007/BF01310496pubmed: 1848747google scholar: lookup
              37. Carpenter S, Alexandersen S, Long MJ, Perryman S, Chesebro B. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus.. J Virol 1991 Mar;65(3):1605-10.
              38. Chong YH, Ball JM, Issel CJ, Montelaro RC, Rushlow KE. Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus.. J Virol 1991 Feb;65(2):1013-8.
              39. Perryman LE, O'Rourke KI, Mason PH, McGuire TC. Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus.. Immunology 1990 Dec;71(4):592-4.
                pubmed: 1703988
              40. Phillips TR, Talbott RL, Lamont C, Muir S, Lovelace K, Elder JH. Comparison of two host cell range variants of feline immunodeficiency virus.. J Virol 1990 Oct;64(10):4605-13.
              41. Rwambo PM, Issel CJ, Hussain KA, Montelaro RC. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV).. Arch Virol 1990;111(3-4):275-80.
                doi: 10.1007/BF01311062pubmed: 1693846google scholar: lookup
              42. Knowles DP Jr, Cheevers WP, McGuire TC, Brassfield AL, Harwood WG, Stem TA. Structure and genetic variability of envelope glycoproteins of two antigenic variants of caprine arthritis-encephalitis lentivirus.. J Virol 1991 Nov;65(11):5744-50.
              43. Alexandersen S, Carpenter S. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.. J Virol 1991 Aug;65(8):4255-62.
              44. Ball JM, Rushlow KE, Issel CJ, Montelaro RC. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.. J Virol 1992 Feb;66(2):732-42.
                doi: 10.1128/JVI.66.2.732-742.1992pubmed: 1370556google scholar: lookup
              45. Perry ST, Flaherty MT, Kelley MJ, Clabough DL, Tronick SR, Coggins L, Whetter L, Lengel CR, Fuller F. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro.. J Virol 1992 Jul;66(7):4085-97.
              46. Kim CH, Casey JW. Genomic variation and segregation of equine infectious anemia virus during acute infection.. J Virol 1992 Jun;66(6):3879-82.
              47. Issel CJ, Horohov DW, Lea DF, Adams WV Jr, Hagius SD, McManus JM, Allison AC, Montelaro RC. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.. J Virol 1992 Jun;66(6):3398-408.